撤稿：康柏西普治疗视网膜静脉阻塞后黄斑水肿复发的预后因素研究：FALCON研究的事后分析
Retracted: Prognostic Factor Study of Macular Edema Recurrence in Retinal Vein Occlusion after Conbercept Treatment: A Post Hoc Analysis of the FALCON Study.
作者信息
Methods In Medicine Computational And Mathematical
出版信息
Comput Math Methods Med. 2023 Dec 6;2023:9858407. doi: 10.1155/2023/9858407. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2022/3616044.].
摘要
[本文撤回文章DOI: 10.1155/2022/3616044。]
相似文献
1
Retracted: Prognostic Factor Study of Macular Edema Recurrence in Retinal Vein Occlusion after Conbercept Treatment: A Post Hoc Analysis of the FALCON Study.撤稿：康柏西普治疗视网膜静脉阻塞后黄斑水肿复发的预后因素研究：FALCON研究的事后分析
Comput Math Methods Med. 2023 Dec 6;2023:9858407. doi: 10.1155/2023/9858407. eCollection 2023.
2
Prognostic Factor Study of Macular Edema Recurrence in Retinal Vein Occlusion after Conbercept Treatment: A Post Hoc Analysis of the FALCON Study.康柏西普治疗视网膜静脉阻塞继发黄斑水肿复发的预后因素研究：一项 FALCON 研究的事后分析。
Comput Math Methods Med. 2022 Jul 29;2022:3616044. doi: 10.1155/2022/3616044. eCollection 2022.
3
Conbercept improves macular microcirculation and retinal blood supply in the treatment of nonischemic branch retinal vein occlusion macular edema.康柏西普改善非缺血型分支静脉阻塞性黄斑水肿患者的黄斑区微循环及视网膜血流供应。
J Clin Lab Anal. 2022 Dec;36(12):e24774. doi: 10.1002/jcla.24774. Epub 2022 Nov 21.
4
Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion.康柏西普治疗视网膜静脉阻塞继发黄斑水肿后对微血管结构变化的评估。
Biomed Res Int. 2020 Jun 19;2020:9046781. doi: 10.1155/2020/9046781. eCollection 2020.
5
The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion.康柏西普治疗视网膜静脉阻塞所致黄斑水肿的抗炎抗氧化作用。
Biochem Biophys Res Commun. 2019 Jan 22;508(4):1264-1270. doi: 10.1016/j.bbrc.2018.12.049. Epub 2018 Dec 15.
6
Comparison of Conbercept with Ranibizumab for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion.康柏西普与雷珠单抗治疗视网膜分支静脉阻塞继发黄斑水肿的比较
Curr Eye Res. 2017 Aug;42(8):1174-1178. doi: 10.1080/02713683.2017.1285943. Epub 2017 Apr 25.
7
Predictors of visual recovery in patients with macular edema secondary to central retinal vein occlusion after treatment with Conbercept.康柏西普治疗视网膜中央静脉阻塞继发黄斑水肿患者的视力恢复的预测因素。
BMC Ophthalmol. 2021 Nov 22;21(1):402. doi: 10.1186/s12886-021-02174-0.
8
AQUEOUS HUMOR CYTOKINE LEVELS AND REBOUND MACULAR EDEMA AFTER CONBERCEPT TREATMENT IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION.康柏西普治疗中心性视网膜静脉阻塞后房水细胞因子水平和黄斑水肿反弹。
Retina. 2021 Apr 1;41(4):834-843. doi: 10.1097/IAE.0000000000002918.
9
OPTICAL COHERENCE TOMOGRAPHY PREDICTORS OF SHORT-TERM VISUAL ACUITY IN EYES WITH MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL CONBERCEPT.玻璃体内注射康柏西普治疗视网膜静脉阻塞继发黄斑水肿患者短期视力的光学相干断层扫描预测指标
Retina. 2020 Apr;40(4):773-785. doi: 10.1097/IAE.0000000000002444.
10
Effect of Conbercept Treatment on Macular Edema and Microvascular Structure in Eyes with Retinal Vein Occlusions.康柏西普治疗对视网膜静脉阻塞患者眼部黄斑水肿及微血管结构的影响
Int J Gen Med. 2022 Sep 15;15:7311-7318. doi: 10.2147/IJGM.S373015. eCollection 2022.
本文引用的文献
1
Prognostic Factor Study of Macular Edema Recurrence in Retinal Vein Occlusion after Conbercept Treatment: A Post Hoc Analysis of the FALCON Study.康柏西普治疗视网膜静脉阻塞继发黄斑水肿复发的预后因素研究：一项 FALCON 研究的事后分析。
Comput Math Methods Med. 2022 Jul 29;2022:3616044. doi: 10.1155/2022/3616044. eCollection 2022.
Zotero 插件